Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CASI PHARMACEUTICALS, INC.

(CASI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Trends: 90-Day Insider Selling Trend at CASI Pharmaceuticals Slowed with Acquisition of Shares

11/24/2020 | 05:42pm EDT


ę MT Newswires 2020
All news about CASI PHARMACEUTICALS, INC.
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell 2000 Value Inde..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell Small Cap Compl..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell 2500 Value Inde..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell Microcap Value ..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell 3000E Growth In..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell 3000E Index
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell 3000 Value Inde..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell 3000 Growth Ind..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell Small Cap Comp ..
CI
06/25CASI PHARMACEUTICALS, INC.(NASDAQCM : CASI) dropped from Russell Small Cap Comp ..
CI
More news
Financials (USD)
Sales 2021 25,2 M - -
Net income 2021 -40,5 M - -
Net cash 2021 57,3 M - -
P/E ratio 2021 -3,88x
Yield 2021 -
Capitalization 164 M 164 M -
EV / Sales 2021 4,22x
EV / Sales 2022 4,59x
Nbr of Employees 144
Free-Float 70,0%
Chart CASI PHARMACEUTICALS, INC.
Duration : Period :
CASI Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CASI PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 1,17 $
Average target price 4,20 $
Spread / Average Target 259%
EPS Revisions
Managers and Directors
Wei-Wu He Executive Chairman & Chief Executive Officer
Wei Zhang President
Alexander A. Zukiwski Chief Medical Officer
Cynthia Wong Hu COO, Secretary, Vice President & General Counsel
Zuie Chin Huang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CASI PHARMACEUTICALS, INC.-60.34%173
MODERNA, INC.221.50%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.38.02%47 396
CELLTRION, INC.-26.60%31 265
SEAGEN INC.-18.34%25 955